enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. CRISPR Therapeutics - Wikipedia

   en.wikipedia.org/wiki/CRISPR_Therapeutics

   CRISPR Therapeutics was founded in 2013 by Emmanuelle Charpentier, Shaun Foy and Rodger Novak. [6] Charpentier later shared the Nobel Prize in Chemistry in 2020 with Jennifer Doudna. As part of a working group, she provided the first scientific documentation on the development and use of CRISPR gene editing. This allows DNA to be specifically ...

3. 3 Things You Need to Know if You Buy CRISPR Therapeutics Today

   www.aol.com/3-things-know-buy-crispr-144500442.html

   CRSP Market Cap data by YCharts. 3. Intensive competition. The success of CRISPR Therapeutics will depend on its ability to bring multiple new drugs to the market to support a more viable business ...

4. CRISPR Therapeutics Presents Data at the 2024 American ...

   lite.aol.com/tech/story/0022/20241209/9316263.htm

   ZUG, Switzerland and BOSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and efficacy of CTX112™, a ...

5. Where Will CRISPR Therapeutics Be in 3 Years? - AOL

   www.aol.com/finance/where-crispr-therapeutics-3...

   CRISPR Therapeutics (NASDAQ: CRSP) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. But don't expect CRISPR to try to offload ...

6. CRISPR Therapeutics Provides Business Update and Reports ...

   lite.aol.com/tech/story/0022/20241105/9267676.htm

   CRISPR Therapeutics has two next generation approaches with the potential to significantly expand the addressable population with SCD and TDT. The Company continues to advance its internally developed targeted conditioning program, an anti-CD117 (c-Kit) antibody-drug conjugate (ADC), through preclinical studies.

7. Is CRISPR Therapeutics Stock a Buy? - AOL

   www.aol.com/crispr-therapeutics-stock-buy...

   CRISPR Therapeutics (NASDAQ: CRSP) is a star in the gene-editing therapy niche. The company made tremendous progress over the past few years, culminating in its first regulatory approval -- for ...

8. Is CRISPR Therapeutics Stock a Buy? - AOL

   www.aol.com/crispr-therapeutics-stock-buy...

   As a result, CRISPR Therapeutics may soon opt to slow down its initiation of new pre-clinical programs, or (perhaps temporarily) shelve programs rather than advancing them into early stage ...

9. FDA approves two gene therapies for sickle cell, bringing ...

   www.aol.com/fda-expected-approve-first-crispr...

   Casgevy is the CRISPR-based treatment, made by Vertex Pharmaceuticals and Crispr Therapeutics; Lyfgenia, made by bluebird bio, uses an older gene therapy approach. Both were cleared for people 12 ...